Tech Company Financing Transactions
Alzheon Funding Round
Alzheon, based in Framingham, received $100 million from Alerce Medical Technology Partners and private investors.
Transaction Overview
Company Name
Announced On
6/12/2024
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Series E
Investors
Alerce Medical Technology Partners (Lead Investor) (Muneer Satter )
Proceeds Purpose
This latest fundraising ensures that we will have sufficient capital to complete our pivotal Phase 3 program and prepare commercialization of oral ALZ-801/valiltramiprosate with runway well into 2026.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
111 Speen St. 306
Framingham, MA 01701
USA
Framingham, MA 01701
USA
Phone
Website
Email Address
Not Recorded
Overview
Alzheon, Inc., is a clinical-stage biotechnology company focused on brain health, memory and aging, developing a pipeline of innovative.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Martin Tolar
Chief Medical Officer
Susan Abushakra
Chief Scientific Officer
John Hey
Vice President
Aidan Power
VP - Finance
Kenneth Mace
Browse more venture capital transactions:
Prev: 6/12/2024: Stellar venture capital transaction
Next: 6/12/2024: Alida Biosciences venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs